Pentostatin for Treatment of Refractory Autoimmune Lymphoproliferative Syndrome

被引:8
|
作者
Bajwa, Rajinder [1 ]
Savelli, Stephanie [2 ]
Gross, Thomas [1 ]
机构
[1] Nationwide Childrens Hosp, Dept Hematol Oncol BMT, Columbus, OH 43205 USA
[2] Childrens Hosp Med Ctr Akron, Akron, OH USA
关键词
autoimmune cytopenias; autoimmune lymphoproliferative syndrome; pentostatin; refractory ALPS; MYCOPHENOLATE-MOFETIL; SYNDROME ALPS;
D O I
10.1002/pbc.23144
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Autoimmune lymphoproliferative syndrome (ALPS), a disorder of programmed cell death, could be due to a congenital defect in the Fas signaling pathway or other pathways for apoptosis. Most cases present with lymphoproliferation and certain autoimmune features such as thrombocytopenia, neutropenia, and anemia are due to excessive production of antibodies by B lymphocytes. Majority of cases present within the first few years of life. We report a case of ALPS presenting at birth which was refractory to splenectomy and immunosuppressive therapy, but responded to pentostatin followed by hematopoietic stem cell transplantation (HSCT). Pediatr Blood Cancer. 2011;57:336-337. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:336 / 337
页数:2
相关论文
共 50 条
  • [1] Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome
    Bajwa, Rajinder
    Gross, Thomas
    Savelli, Stephanie
    PEDIATRIC BLOOD & CANCER, 2012, 58 (02) : 311 - 311
  • [2] SUCCESSFUL TREATMENT WITH SIROLIMUS IN PATIENTS WITH REFRACTORY AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
    Haerynck, F.
    Logghe, K.
    Bordon, V.
    Neven, B.
    Rieux-Laucat, F.
    De Baets, F.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 54 - 55
  • [3] Pentostatin for the treatment of indolent lymphoproliferative disorders
    Ho, AD
    Hensel, M
    SEMINARS IN HEMATOLOGY, 2006, 43 (02) : S2 - S10
  • [4] Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders
    Goodman, M
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 67 - 71
  • [5] Mycophenolate Mofetil and Thrombopoietin Receptor Agonists in the Treatment of Refractory Thrombocytopenia in Patients with Autoimmune Lymphoproliferative Syndrome
    Chang, Leejah
    Price, Susan
    Perkins, Katie
    Davis, Joie
    Aldridge, Patricia
    Recht, Michael
    Kelleher, John
    Rao, V. Koneti
    BLOOD, 2011, 118 (21) : 965 - 966
  • [6] Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)
    Rao, V. Koneti
    Price, Susan
    Perkins, Katie
    Aldridge, Patricia
    Tretler, Jean
    Davis, Joie
    Dale, Janet K.
    Gill, Fred
    Hartman, Kip R.
    Stork, Linda C.
    Gnarra, David J.
    Krishnamurti, Lakshmanan
    Newburger, Peter E.
    Puck, Jennifer
    Fleisher, Thomas
    PEDIATRIC BLOOD & CANCER, 2009, 52 (07) : 847 - 852
  • [7] Autoimmune lymphoproliferative syndrome
    Naranjo, TA
    Martínez, JMJ
    Artal, EM
    Usach, MTS
    MEDICINA CLINICA, 2001, 117 (20): : 798 - 799
  • [8] Autoimmune lymphoproliferative syndrome
    Oliveira, Joao B.
    Fleisher, Thomas
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 4 (06) : 497 - 503
  • [9] Autoimmune lymphoproliferative syndrome
    Sneller, MC
    Dale, JK
    Straus, SE
    CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (04) : 417 - 421
  • [10] AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
    Cojocaru, Manole
    Cojocaru, Inimioara Mihaela
    Silosi, Isabela
    Vrabie, Camelia Doina
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2010, 29 (01) : 15 - 18